Levothyroxine Sodium Tablets - In Vivo Pharmacokinetic and Bioavailability Studies and In Vitro Dissolution Testing
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 8, 2001
April 24, 2020
74b4ee28-e27e-400e-8b87-ba8701d4ea31
Related Documents
Prussian Blue Drug Products — Submitting a New Drug Application
Guidance DocumentFebruary 4, 2003Center for Drug Evaluation and Research
Alternate Source of the Active Pharmaceutical Ingredient in Pending ANDAs: Guidance for Industry
Guidance DocumentDecember 1, 2000Center for Drug Evaluation and Research
INDs for Phase 2 and Phase 3 Studies Chemistry, Manufacturing, and Controls Information: Guidance for Industry
Guidance DocumentMay 20, 2003Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.